Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ImmunArray

ImmunArray
2006 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of an in-vitro diagnostic platform system designed to to help physicians manage complex autoimmune and neurologic diseases. The company's system is used in the development of microarray devices and informatics that are used in profiling a patient's immune system to detect autoimmune, lung cancer and other diseases, providing physicians with information from proprietary multi-analyte biomarker-based tests.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 12 Hamada Street
  • Entrance A - Floor 2
  • Rehovot 7670315
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ImmunArray’s full profile, request a free trial.

ImmunArray Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 11-Jul-2016 $10M 000.00 Completed Generating Revenue
6. Grant 23-Jan-2014 00000 00.00 Completed Generating Revenue
5. Later Stage VC 15-Apr-2013 00.00 00.00 Completed Generating Revenue
4. Early Stage VC 03-May-2010 00.00 00.00 Completed Startup
3. Grant 22-Dec-2008 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 25-Feb-2008 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ImmunArray Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Asuragen Venture Capital-Backed Austin, TX 000 000.00 00000000000 000.00
000000000 00000000 Formerly VC-backed South San Francisco, CA 000 00000 000000&0 00000
00000000 000000000 Formerly PE-Backed Fremont, CA 000 000 000000000000 000
000000000000000 Venture Capital-Backed San Diego, CA 000 000.00 0000000000 0 000.00
000000000000 Venture Capital-Backed Vancouver, Canada 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

ImmunArray Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Exigent Alternative Capital Asset Manager Minority 000 0000 000000 0
General Electric Corporation 000 0000 000000 0
NFL Pension Plan Limited Partner Minority 000 0000 000000 0
Laszlo N. Tauber Family Foundation Limited Partner Minority 000 0000 000000 0
Virginia Life Science Investments Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

ImmunArray Executive Team (11)

Name Title Board
Seat
Contact
Info
William Kaluza JD Chief Financial Officer
Pennina Safer Ph.D Chief Operating Officer & General Manager, Israel
Irun Cohen MD Co-Founder & Scientific Advisor
Eli Sahar Ph.D Co-Founder
Gail Howerton Vice President, Finance

3 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

ImmunArray Board Members (6)

Name Representing Role Since Contact
Info
Dick Aderman Self Board Member 000 0000
Donna Edmonds Self Chief Executive Officer & Chairman of the Board 000 0000
Robert Sledd Self Board Member 000 0000
Tim Black ImmunArray Board Member 000 0000
Timothy Schroeder Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »